InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.02
(
0.44%
)
Bitcoin
90,605.14
(
0.82%
)
Post# of 253650
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120736
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ariadndndough post# 116934

Thursday, 03/24/2011 12:14:27 PM

Thursday, March 24, 2011 12:14:27 PM

Post# of 253650
MRK thinks Betrixaban is too little too late to compete with the likes of Xarelto, Pradaxa, and Apixaban. Refer to the compilation in #msg-61118114 and it’s easy to see why. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up